Important Patient Update: Mounjaro (Tirzepatide) for Weight Management
You may have seen recent media coverage about the availability of Mounjaro (tirzepatide), a new medication for managing obesity and type 2 diabetes.
As of 23rd June 2025, NHS England has approved Mounjaro for prescribing to specific patient groups under strict eligibility criteria. However, NHS Devon has not yet implemented this service locally, and GP surgeries in Devon have been advised against the independent initiation of tirzepatide (Mounjaro®) prescribing for weight management until the point at which further guidance is provided.
What this means for our patients:
- Please do not contact the surgery to request Mounjaro at this time. We are not yet able to prescribe this medication.
- Once the service is developed and local prescribing is approved, we will update out website and social media and we may contact eligible patients directly at this point. You do not need to take any action now.
We understand this may be disappointing for some patients, and we appreciate your patience and understanding. We will provide updates as soon as local guidance changes.